| Ribostamycin sulfate Basic information |
| Product Name: | Ribostamycin sulfate |
| Synonyms: | Rribostamycin sulfate;Ribostamycin sulfate;D-Streptamine, O-2,6-diamino-2,6-dideoxy-α-D-glucopyranosyl-(1→4)-O-[β-D-ribofuranosyl-(1→5)]-2-deoxy-, sulfate (1:1);Ribose neoMycin sulfate;Ribostamycin s;DTDP-GLUCOSE, DISODIUM SALT;landamycine;o-2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-4)-o-(beta-d-streptamin |
| CAS: | 53797-35-6 |
| MF: | C17H22N4O10S |
| MW: | 474.44238 |
| EINECS: | 258-783-1 |
| Product Categories: | Antibiotics;AminoglycosidesAntibiotics;Antibacterial;Antibiotics A to;Antibiotics by Application;Antibiotics N-SAntibiotics;Chemical Structure Class;Genetic Marker SelectionAntibiotics;Interferes with Protein SynthesisSpectrum of Activity;L - Z;Mechanism of Action |
| Mol File: | 53797-35-6.mol |
| Ribostamycin sulfate Chemical Properties |
| Melting point | 175-180 C |
| alpha | D20 +39° (c = 1) |
| Fp | >110°(230°F) |
| storage temp. | Inert atmosphere,2-8°C |
| solubility | H2O: soluble50mg/mL |
| form | powder |
| color | White to Off-White |
| Water Solubility | Soluble in water |
| Merck | 14,8206 |
| Stability: | Hygroscopic |
| Safety Information |
| Hazard Codes | T,Xi |
| Risk Statements | 61-20/21/22-36/38 |
| Safety Statements | 53-22-36/37/39-45-37/39-26 |
| WGK Germany | 3 |
| RTECS | WK2300000 |
| Toxicity | LD50 i.v. in mice: 225 mg/kg (Shomura) |
| MSDS Information |
| Ribostamycin sulfate Usage And Synthesis |
| Uses | Antibacterial;Ribosomal protein synthesis inhibitor |
| Uses | Ribostamycin is a broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus. It is used in pharmacokinetic and nephrotoxicity studies. |
| Definition | ChEBI: An aminoglycoside sulfate salt resulting from the reaction of ribostamycin with sulfuric acid. |
| Ribostamycin sulfate Preparation Products And Raw materials |
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.